Literature DB >> 3200320

Receptors bound to antiprogestin from abortive complexes with hormone responsive elements.

A Guiochon-Mantel1, H Loosfelt, T Ragot, A Bailly, M Atger, M Misrahi, M Perricaudet, E Milgrom.   

Abstract

The mechanism of action of antisteroids is not understood and explanations of their antagonistic activity have been sought at all levels of hormone action. It has been proposed that antisteroids, after binding to receptor, trap it into a non-activated (non DNA-binding) form possibly through interaction with a heat-shock protein of relative molecular mass (Mr) 90,000 (90 K), or that the antisteroids provoke binding of receptor to nonspecific DNA sites but not to hormone responsive elements (HREs), or that the antisteroid-receptor complexes can bind to HREs but form abortive complexes that fail to regulate transcription. We have constructed a deleted cDNA encoding a mutant form of rabbit progesterone receptor which exhibits constitutive activity, that is, binds to HREs in the absence of hormone and thus bypasses the first two steps discussed above. Co-transfection experiments allowed the expression of both constitutive and wild-type receptors in the same recipient cells. Antiprogestin RU486-wild-type receptor complexes completely suppressed the activity of the constitutive receptor on a reporter gene, showing that the inhibition is at the level of their common responsive elements.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3200320     DOI: 10.1038/336695a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers.

Authors:  T A Pham; J F Elliston; Z Nawaz; D P McDonnell; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Clinical pharmacokinetics of mifepristone.

Authors:  O Heikinheimo
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

3.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.

Authors:  L Klein-Hitpass; A C Cato; D Henderson; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

4.  Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending.

Authors:  A M Nardulli; D J Shapiro
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

5.  Repression of the alpha-fetoprotein gene promoter by progesterone and chimeric receptors in the presence of hormones and antihormones.

Authors:  B Turcotte; M E Meyer; M T Bocquel; L Bélanger; P Chambon
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific.

Authors:  M T Bocquel; V Kumar; C Stricker; P Chambon; H Gronemeyer
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

7.  In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA.

Authors:  K Delabre; A Guiochon-Mantel; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  Nuclear localization signals also mediate the outward movement of proteins from the nucleus.

Authors:  A Guiochon-Mantel; K Delabre; P Lescop; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

9.  Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo.

Authors:  M Truss; J Bartsch; M Beato
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 10.  Mechanisms of hormone resistance in breast cancer.

Authors:  K B Horwitz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.